LY338979;N-[4-[2-(2-AMino-4,5,6,7-tetrahydro-4,6-dioxo-1H-pyrrolo[2,3-d]pyriMidin-5-yl)ethyl]benzoyl]-L-glutaMicAcid;PeMetrexedIMpurity(MixtureofDiastereoMers)(N-[4-[2-(2-AMino-4,5,6,7-teChemicalbooktrahydro-4,6-dioxo-1H-pyrrolo[2.3-d]-pyriMidi;Pemetrexed6-OxoDiacidImpurity;PemetrexedImpurity18;PemetrexedKetoimpurity;Pemetrexedimpurities7;Pemetrexed6-OxoDiacidImpurity(ketopemetrexed)
Pemetrexed Impurity refers to process-related substances or degradants generated during the synthesis of the anticancer drug Pemetrexed. These impurities are critical for quality control, ensuring the final pharmaceutical product meets international purity standards. The molecular formula and CAS number vary depending on the specific isomer or byproduct structure.
Store strictly under inert atmosphere at controlled temperatures (2-8°C) to prevent degradation. Handle with appropriate PPE including gloves and masks due to potential cytotoxicity. Avoid direct contact and ensure proper ventilation in laboratory settings.